UNSPSC 51334304: Prothixene

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51334304

Definition

This classification denotes a sedative and hypnotic with the molecular formula C18H19NS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2HX2OJH78L, chemically known as n,n-dimethylthioxanthene-delta(sup 9,gamma)-propylamine but generally known as prothixene, which bears US NIH Compound Identifier 71115. European Medicines Agency schedules Prothixene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10139MIG.

Read the full definition

The term PROTHIXENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). PROTHIXENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule prothixene under HS 29349990 and SITC 51579. As of Q4 2014, PROTHIXENE remains the US FDA Preferred Term for this commodity. Prothixene bears US NLM identifiers UMLS ID C0072428 and NCI Concept Code C73249. SMILES: S1C2C(C(=C\CCN(C)C)/C3C1CCCC3)CCCC2.

About UNSPSC 51334304

UNSPSC 51334304 Prothixene is a Commodity code that describes pharmaceutical products used in emergency medical response and harm reduction. Recent state and local procurement under this code centers on naloxone acquisition — a life-saving opioid antagonist — and complementary drug deactivation systems deployed through community health initiatives and emergency response networks. Issuing bodies soliciting under the code include county health departments and community health agencies operating at the municipal and regional level. The work involves competitive procurement of finished pharmaceutical units with quarterly delivery schedules, standardized vendor compliance requirements including E-Verify authorization and drug-free workplace certification, and fixed-fee pricing models with multi-year contract terms and renewal options.

Seminole County, Florida posted an IFB (Invitation for Bid) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement required vendors to submit bids through the county's e-Procurement Portal with all shipping and delivery costs included, maintain workers' compensation and commercial general liability insurance, and comply with federal requirements including the Clean Air Act and Federal Water Pollution Control Act when FEMA funding applied. The contract included a two-year initial term with a one-year renewal option and a three-month probationary termination provision. The source provides limited visibility into geographic concentration beyond Florida; no other recent opportunities under this Commodity code are reported.

Quick answers

What is UNSPSC 51334304?

UNSPSC 51334304 is Prothixene, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51334304?

UNSPSC 51334304 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51334304

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code